 circadian infus floxuridin patient metastat renal cell carcinoma total patient metastat renal cell carcinoma floxuridin infus day monthli interv drug extern programm pump time-modifi circadian schedul dose patient undergon prior nephrectomi evalu patient confidenti interv partial respons undergon prior nephrectomi undergon renal angioinfarct patient respons metastat site respons primari kidney tumor median durat respons group patient week respons site lung treatment outpati basi studi limit definit activ floxuridin circadian schedul patient metastat renal cell carcinoma respons metastasi patient prior nephrectomi